GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Alkermes, Inc. (ALKS) [hlAlert]

Rating:
Overweight
ALKS
up 50.98 %

Alkermes, Inc. (ALKS) upgraded to Overweight by Morgan Stanley

Posted on: Thursday,  Jan 10, 2013  8:25 AM ET by Morgan Stanley

Morgan Stanley rated Overweight Alkermes, Inc. (NASDAQ: ALKS) on 01/10/2013, when the stock price was $21.77. Since then, Alkermes, Inc.
has gained 50.99% of its value until Morgan Stanley rated ALKS Equal-Weight on 10/01/2013, when the price was $32.87.
If you would have followed this Morgan Stanley's recommendation on ALKS, you would have gained 50.98% of your investment in 264 days.

Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes currently has two commercial products: RISPERDAL CONSTA, the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag, a wholly owned division of Johnson & Johnson; and VIVITROL the first and only once-monthly injectable medication approved for the treatment of alcohol dependence and marketed in the U.S. primarily by Cephalon, Inc. Alkermes' pipeline includes extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases such as central nervous system disorders, addiction and diabetes.

Morgan Stanley Investment Research is one of the financial industry's dominant thought leaders in equity and fixed-income investing. Our analysts, economists, and strategists have earned this reputation through timely, in-depth analysis of companies, industries, markets, and the world’s economies. Our teams collaborate to assist Morgan Stanley clients with investment decisions, using cash and derivative instruments across major asset classes and geographies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/21/2016 5:25 PM Sell
None
as of 12/13/2013
1 Week   
1 Month   
3 Months down  -4.11 %
1 YTD up  50.98 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/1/2013 8:25 AM Hold
None
32.87
1/10/2013 8:25 AM Buy
None
21.77
11/27/2012 8:25 AM Hold
None
19.89

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy